Archives202520242023202220212020201920182017201620152014201320122011 March 25, 2024Incanthera Provides Commercial Update and Revenue Forecasts Read More March 19, 2024Grant of Share Options Read More March 14, 2024IMMUPHARMA AT BIO-EUROPE SPRING 2024. 18-20 March 2024 | Barcelona Read More March 06, 2024Financial, Business and Portfolio Development Update Read More January 02, 2024TR1 – Major Holding by Lanstead (Date: 28 December 2023) Read More December 20, 2023TR1 – Major holding by Lanstead Read More December 19, 2023Simbec-Orion appointed as CRO | Decision to move directly into a Phase 3 pivotal study | Compelling findings on P140’s MOA Read More December 18, 2023Incanthera Secures Commercial Skincare Deal & £1M Fundraise Read More September 14, 2023Major shareholding by Lanstead via TR1 Read More September 07, 2023Result of retail offer and Director shareholding Read More September 06, 2023Major shareholding from Lanstead Capital via TR1 Read More August 31, 2023Subscriptions to raise £1.35 million; Sharing Agreement; WRAP Retail Offer to raise up to £0.5 million • Related Party Transactions Read More 12345…23
December 19, 2023Simbec-Orion appointed as CRO | Decision to move directly into a Phase 3 pivotal study | Compelling findings on P140’s MOA Read More
August 31, 2023Subscriptions to raise £1.35 million; Sharing Agreement; WRAP Retail Offer to raise up to £0.5 million • Related Party Transactions Read More
